exit
52 articole · RSS
Enterprise Investors contemplates exit from Macon Deva in three years
Polish investment fund Enterprise Investors, which owns construction materials producer Macon Deva, might exit the company in 2011, after it recently bought Simcor Oradea in a deal worth 53...
Enterprise Investors: Luam in calcul un exit din Macon Deva peste trei ani
Polonezii vor investi circa 17-18 milioane de euro in urmatorii trei ani in extinderea capacitatilor de productie a Simcor Oradea. "Vrem sa cream un jucator puternic pe piata de BCA pe care...
Enterprise Investors: Luam in calcul un exit din Macon Deva peste trei ani
Fondul de investitii polonez Enterprise Investors, care detine producatorul de materiale de constructii Macon Deva, ar putea derula un exit din cadrul companiei in 2011, dupa ce a achizition...
AAA Auto could exit the market due to poor sales
Four years after it entered the domestic market, Czech used car dealer AAA Auto is considering exiting the market. The company achieved only one third of the 7,000-unit sales targeted for 20...
Exit poll: Sorin Oprescu a castigat Primaria Capitalei cu 54,3% din voturi
Sorin Oprescu (independent) este noul primar general al Capitalei, dupa ce a castigat 54,3% din voturile bucurestenilor, potrivit unui sondaj INSOMAR, comandat de postul de televiziune Reali...
Bodo: Continental Hotels exit, his most difficult deal
Francisc Bodo, former chief investment officer with GED private equity company, says the exit from Continental Hotels was the most difficult deal he has participated in, with the listing of...
LaborMed, most profitable exit from CEE market
LaborMed Pharma, Terapia and Sindan, the three major drug makers sold over the past three years, were some of the most profitable for sellers, according to a survey conducted by A.T. Kearney...
AT Kearney: fondatorii LaborMed au realizat cel mai profitabil exit de pe piata farmaceutica central si est europeana
Studiul realizat de A.T. Kearney si furnizat Ziarului Financiar arata care au fost cele mai importante tranzactii din Europa de Sud Est in ultimii doi ani in piata farmaceutica si la ce mult...
AT Kearney: fondatorii LaborMed au realizat cel mai profitabil exit de pe piata farmaceutica central si est europeana
Cei trei mari producatori de medicamente vanduti in ultimii trei ani, LaborMed Pharma, Terapia si Sindan, au fost printre cei mai profitabili pentru vanzatori, releva un studiu al companiei...